Free Trial

LexinFintech (NASDAQ:LX) Trading 11.8% Higher - Time to Buy?

LexinFintech logo with Finance background

LexinFintech Holdings Ltd. Sponsored ADR (NASDAQ:LX - Get Free Report) rose 11.8% on Wednesday . The stock traded as high as $7.70 and last traded at $7.89. Approximately 1,851,331 shares were traded during trading, a decline of 45% from the average daily volume of 3,354,804 shares. The stock had previously closed at $7.05.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of LexinFintech from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 27th.

Get Our Latest Report on LexinFintech

LexinFintech Stock Performance

The stock's 50-day simple moving average is $7.33 and its two-hundred day simple moving average is $7.92. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.85 and a current ratio of 1.85. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of 6.53 and a beta of 0.41.

LexinFintech (NASDAQ:LX - Get Free Report) last posted its earnings results on Wednesday, May 21st. The company reported $0.33 earnings per share for the quarter. The business had revenue of $427.76 million for the quarter. LexinFintech had a net margin of 9.44% and a return on equity of 12.52%.

LexinFintech announced that its Board of Directors has authorized a stock buyback program on Monday, July 21st that permits the company to buyback $0.00 in outstanding shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company's management believes its shares are undervalued.

Hedge Funds Weigh In On LexinFintech

Large investors have recently modified their holdings of the stock. Aigen Investment Management LP acquired a new position in shares of LexinFintech during the first quarter worth approximately $103,000. Janney Montgomery Scott LLC bought a new position in LexinFintech in the second quarter valued at approximately $75,000. Ameriprise Financial Inc. bought a new position in LexinFintech in the fourth quarter valued at approximately $61,000. CreativeOne Wealth LLC bought a new position in LexinFintech in the first quarter valued at approximately $107,000. Finally, Ballentine Partners LLC bought a new position in LexinFintech in the second quarter valued at approximately $86,000.

LexinFintech Company Profile

(Get Free Report)

LexinFintech Holdings Ltd., through its subsidiaries, provides online consumer finance services in the People's Republic of China. The company operates Fenqile.com, an online consumption and consumer finance platform that offers installment purchase and personal installment loans, as well as online direct sales with installment payment terms; and Le Hua Card, a scenario-based lending.

Further Reading

Should You Invest $1,000 in LexinFintech Right Now?

Before you consider LexinFintech, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LexinFintech wasn't on the list.

While LexinFintech currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines